| Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination. | |
| | |
MedLine Citation:
|
PMID: 23379766 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: This study aimed to compare the outcome of patients with severe community-acquired pneumonia (SCAP) treated with the combination of either β-lactam-quinolone (βQ) or β-lactam-macrolide (βM) antibiotics. METHODS: We retrospectively studied a cohort of patients with SCAP treated from January 2000 to December 2010 at a mixed university-level intensive care unit (ICU). APACHE II score, SCAP severity assessed by IDSA/ATS score, first antibiotic treatment initiated during the initial 24 h of admission, ICU and hospital length of stay (LOS), and ICU, hospital, 30 and 60-day mortalities were assessed. RESULTS: Altogether, 210 patients with SCAP were analyzed, 104 in the βQ arm and 106 in the βM arm. Median APACHE II scores on admission were higher in the βM group (22 vs. 18, P = 0.003). More patients in the βQ group required mechanical ventilation (63.1% vs. 42.5%, P = 0.004) and fulfilled IDSA/ATS SCAP criteria (n = 87; 83.7%) than those in the βM group (n = 73; 68.9%; P = 0.015). Thirty-day mortality was 16.3% in the βQ group and 24.5% in the βM group (P = 0.17), and with septic shock mortality was 19.6% and 32.6%, respectively (P = 0.16). On APACHE II and IDSA/ATS SCAP score adjusted multivariate logistic regression analysis, the βM group had a slightly higher but not significant odds ratio (OR) for a 30-day mortality compared to the βQ group (OR 1.4; 95% CI, 0.62-3.0; P = 0.44). CONCLUSION: Thirty-day mortality rate of SCAP patients did not differ whether they were treated with either βQ or βM combination. |
| | |
Authors:
|
J Karhu; T I Ala-Kokko; P Ohtonen; H Syrjälä |
Related Documents
:
|
8671966 - Iga nephropathy in patients over 50 years of age: a multicentre, prospective study. 15206026 - Bartter syndrome: benefits and side effects of long-term treatment. 23036896 - Efficacy and safety of apixaban compared with warfarin according to patient risk of str... 16566976 - Sutureless nephron-sparing surgery: use of albumin glutaraldehyde tissue adhesive (biog... 15511456 - Postpericardiotomy syndrome after permanent pacemaker implantation in children and youn... 19472086 - Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive c... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-2-5 |
Journal Detail:
|
Title: Acta anaesthesiologica Scandinavica Volume: - ISSN: 1399-6576 ISO Abbreviation: Acta Anaesthesiol Scand Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-2-5 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370270 Medline TA: Acta Anaesthesiol Scand Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2013 The Acta Anaesthesiologica Scandinavica Foundation. |
Affiliation:
|
Department of Anaesthesiology, Division of Intensive Care, Oulu University Hospital, Oulu, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PTEN modulators: a patent review.
Next Document: The hindgut lumen prokaryotic microbiota of the termite Reticulitermes flavipes and its responses to...